In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.

Q: SECTION 1. INCENTIVES TO INCREASE USE OF HIV SCREENING TESTS UNDER THE 
              MEDICAID PROGRAM.

    (a) Higher Federal Matching Percentage for Routine HIV Screening 
Services.--Section 1903 of the Social Security Act (42 U.S.C. 1396b) is 
amended--
            (1) in subsection (a)--
                    (A) by redesignating paragraph (7) as paragraph 
                (8); and
                    (B) by inserting after paragraph (6) the following 
                new paragraph:
            ``(7) an amount equal to 90 percent of the sums expended 
        during such quarter which are attributable to the costs of 
        providing routine HIV screening services (as defined in 
        subsection (aa)(1)) if the conditions described in subsection 
        (aa)(2) are met; plus''; and
            (2) by adding at the end the following new subsection:
    ``(aa) Routine HIV Screening Services.--
            ``(1) In general.--For purposes of this section, the term 
        `routine HIV screening services' means the following:
                    ``(A) An HIV screening test (and, if such test is 
                positive, a confirmatory HIV test), including the 
                interpretation of such tests, that is provided as part 
                of medical care in any health care setting (other than 
                an inpatient hospital setting) for an individual who--
                            ``(i) is at least 13, but not more than 64, 
                        years of age;
                            ``(ii) is not known to the health care 
                        provider (directly, through information 
                        provided by the individual, or through access 
                        to an electronic medical record) previously 
                        ever to have had a positive test for HIV or, 
                        subject to paragraph (3), within the previous 6 
                        months to have had any test for HIV; and
                            ``(iii) has been informed that such a test 
                        will be administered and has not objected to 
                        such a test.
                    ``(B) Informing an individual so tested of the 
                results of the tests at the time of such examination.
                    ``(C) In the case of such an individual who tests 
                positive for HIV on the screening and confirmatory 
                tests, post-test counseling concerning HIV at the time, 
                and as part of, such examination.
            ``(2) Conditions.--For purposes of subsection (a)(7), the 
        conditions of this paragraph, with respect to routine HIV 
        screening services, are that--
                    ``(A) the payment amount for such services under 
                this title is reasonable and closely approximates the 
                payment amount for such services under part B of title 
                XVIII;
                    ``(B) no cost-sharing is imposed under this title 
                for the provision of such services; and
                    ``(C) in the case of a State for which a political 
                subdivision is required to contribute towards the non-
                Federal share of expenditures for routine HIV screening 
                services, the increase in the Federal share applicable 
                under subsection (a)(5) to such services is first 
                applied to reduce the contribution (but not below zero) 
                required by such political subdivision.
            ``(3) Exception.--The limitation under paragraph (1)(A)(ii) 
        with respect to having a test for HIV within the previous 6 
        months shall not apply to an individual if the individual 
        indicates that, because of the individual's possible exposure 
        to HIV during the intervening period, the individual is at 
        increased risk of acquiring HIV since such previous test.''.
    (b) Conforming Amendments.--
            (1) Subparagraphs (E) and (F) of section 1919(h)(2) of such 
        Act (42 U.S.C. 1396r(h)(2)) are each amended by striking 
        ``1903(a)(7)'' and inserting ``1903(a)(8)''.
            (2) Paragraphs (1) and (2) of section 1931(h) of such Act 
        (42 U.S.C. 1396u-1(h)) are each amended by striking 
        ``1903(a)(7)'' and inserting ``1903(a)(8)''.
            (3) Section 1938(d)(4) of such Act (42 U.S.C. 1396u-
        8(d)(4)) is amended by striking ``1903(a)(7)'' and inserting 
        ``1903(a)(8)''.
            (4) Section 1940(j) of such Act (42 U.S.C. 1396w(j)) is 
        amended by striking ``paragraph (7)'' and inserting ``paragraph 
        (8)''.
    (c) Effective Date.--The amendments made by subsection (a) shall 
apply to services furnished on or after the date of the enactment of 
this Act.
    (d) Report.--Not later 2 years after the date of the enactment of 
this Act, the Secretary of Health and Human Services shall submit a 
report to Congress on barriers that exist for Medicaid beneficiaries to 
access routine HIV screening services (as defined in section 1903(aa) 
of the Social Security Act, as added by subsection (a)(2)). Such report 
shall include recommendations on how to reduce such barriers to access 
such services.

A: Amends title XIX (Medicaid) of the Social Security Act to direct the Secretary of Health and Human Services (HHS) to make quarterly payments to states with Medicaid plans for 90% of their expenditures for routine HIV screening services.
****
Q: SECTION 1. DEVELOPMENT OF BEST PRACTICES FOR THE USE OF PRESCRIPTION 
              OPIOIDS.

    (a) Definitions.--In this section--
            (1) the term ``Secretary'' means the Secretary of Health 
        and Human Services; and
            (2) the term ``task force'' means the Pain Management Best 
        Practices Inter-Agency Task Force convened under subsection 
        (b).
    (b) Inter-Agency Task Force.--Not later than December 14, 2018, the 
Secretary, in cooperation with the Secretary of Veterans Affairs, the 
Secretary of Defense, and the Administrator of the Drug Enforcement 
Administration, shall convene a Pain Management Best Practices Inter-
Agency Task Force to review, modify, and update, as appropriate, best 
practices for pain management (including chronic and acute pain) and 
prescribing pain medication.
    (c) Membership.--The task force shall be comprised of--
            (1) representatives of--
                    (A) the Department of Health and Human Services;
                    (B) the Department of Veterans Affairs;
                    (C) the Food and Drug Administration;
                    (D) the Department of Defense;
                    (E) the Drug Enforcement Administration;
                    (F) the Centers for Disease Control and Prevention;
                    (G) the Health Resources and Services 
                Administration;
                    (H) the Indian Health Service;
                    (I) the National Academy of Medicine;
                    (J) the National Institutes of Health;
                    (K) the Office of National Drug Control Policy;
                    (L) the Substance Abuse and Mental Health Services 
                Administration; and
                    (M) the Office of Women's Health;
            (2) State medical boards;
            (3) subject to subsection (e), physicians, dentists, and 
        nonphysician prescribers;
            (4) hospitals;
            (5) subject to subsection (e), pharmacists and pharmacies;
            (6) first responders;
            (7) experts in the fields of pain research and addiction 
        research;
            (8) experts in the fields of adolescent and young adult 
        addiction research;
            (9) representatives of--
                    (A) pain management professional organizations;
                    (B) the mental health treatment community;
                    (C) the addiction treatment and recovery community;
                    (D) pain advocacy groups;
                    (E) veteran service organizations; and
                    (F) groups with expertise on overdose reversal;
            (10) a person in recovery from addiction to medication for 
        chronic pain;
            (11) a person in recovery from addiction to medication for 
        chronic pain, whose addiction began in adolescence or young 
        adulthood;
            (12) a person with chronic pain;
            (13) an expert on active duty military, armed forces 
        personnel, and veteran health and prescription opioid 
        addiction;
            (14) an expert in the field of minority health; and
            (15) other stakeholders, as the Secretary determines 
        appropriate.
    (d) Condition on Participation on Task Force.--An individual 
representing a profession or entity described in paragraph (3) or (5) 
of subsection (c) may not serve as a member of the task force unless 
such individual--
            (1) is currently licensed in a State in which such 
        individual is practicing (as defined by such State) such 
        profession (or, in the case of an individual representing an 
        entity, a State in which the entity is engaged in business); 
        and
            (2) is currently practicing (as defined by such State) such 
        profession (or, in the case of an individual representing an 
        entity, the entity is in operation).
    (e) Duties.--The task force shall--
            (1) not later than 180 days after the date on which the 
        task force is convened under subsection (b), review, modify, 
        and update, as appropriate, best practices for pain management 
        (including chronic and acute pain) and prescribing pain 
        medication, taking into consideration--
                    (A) existing pain management research;
                    (B) research on trends in areas and communities in 
                which the prescription opioid abuse rate and fatality 
                rate exceed the national average prescription opioid 
                abuse rate and fatality rate;
                    (C) recommendations from relevant conferences and 
                existing relevant evidence-based guidelines;
                    (D) ongoing efforts at the State and local levels 
                and by medical professional organizations to develop 
                improved pain management strategies, including 
                consideration of differences within and between classes 
                of opioids, the availability of opioids with abuse 
                deterrent technology, and pharmacological, 
                nonpharmacological, medical device alternatives to 
                opioids to reduce opioid monotherapy in appropriate 
                cases and the coordination of information collected 
                from State prescription drug monitoring programs for 
                the purpose of preventing the diversion of pain 
                medication;
                    (E) ongoing efforts at the Federal, State, and 
                local levels to examine the potential benefits of 
                electronic prescribing of opioids, including any public 
                comments collected in the course of those efforts;
                    (F) the management of high-risk populations, other 
                than populations who suffer pain, who--
                            (i) may use or be prescribed 
                        benzodiazepines, alcohol, and diverted opioids; 
                        or
                            (ii) receive opioids in the course of 
                        medical care;
                    (G) the distinct needs of adolescents and young 
                adults with respect to pain management, pain 
                medication, substance use disorder, and medication-
                assisted treatment;
                    (H) the 2016 Guideline for Prescribing Opioids for 
                Chronic Pain issued by the Centers for Disease Control 
                and Prevention;
                    (I) the practice of co-prescribing naloxone for 
                both pain patients receiving chronic opioid therapy and 
                patients being treated for opioid use disorders;
                    (J) research that has been, or is being, conducted 
                or supported by the Federal Government on prevention 
                of, treatment for, and recovery from substance use by 
                and substance use disorders among adolescents and young 
                adults relative to any unique circumstances (including 
                social and biological circumstances) of adolescents and 
                young adults that may make adolescent-specific and 
                young adult-specific treatment protocols necessary, 
                including any effects that substance use and substance 
                use disorders may have on brain development and the 
                implications for treatment and recovery;
                    (K) Federal non-research programs and activities 
                that address prevention of, treatment for, and recovery 
                from substance use by and substance use disorders among 
                adolescents and young adults, including an assessment 
                of the effectiveness of such programs and activities 
                in--
                            (i) preventing substance use by and 
                        substance use disorders among adolescents and 
                        young adults;
                            (ii) treating such adolescents and young 
                        adults in a way that accounts for any unique 
                        circumstances faced by adolescents and young 
                        adults; and
                            (iii) supporting long-term recovery among 
                        adolescents and young adults; and
                    (L) gaps that have been identified by Federal 
                officials and experts in Federal efforts relating to 
                prevention of, treatment for, and recovery from 
                substance use by and substance use disorders among 
                adolescents and young adults, including gaps in 
                research, data collection, and measures to evaluate the 
                effectiveness of Federal efforts, and the reasons for 
                such gaps;
            (2) solicit and take into consideration public comment on 
        the practices developed under paragraph (1), amending such best 
        practices if appropriate;
            (3) develop a strategy for disseminating information about 
        the best practices developed under paragraphs (1) and (2) to 
        prescribers, pharmacists, State medical boards, educational 
        institutions that educate prescribers and pharmacists, and 
        other parties, as the Secretary determines appropriate;
            (4) review, modify, and update best practices for pain 
        management and prescribing pain medication, specifically as it 
        pertains to physician education and consumer education; and
            (5) examine and identify--
                    (A) the extent of the need for the development of 
                new pharmacological, nonpharmacological, and medical 
                device alternatives to opioids;
                    (B) the current status of research efforts to 
                develop such alternatives; and
                    (C) the pharmacological, nonpharmacological, and 
                medical device alternatives to opioids that are 
                currently available that could be better utilized.
    (f) Consideration of Study Results.--In reviewing, modifying, and 
updating, best practices for pain management and prescribing pain 
medication, the task force shall take into consideration existing 
private sector, State, and local government efforts related to pain 
management and prescribing pain medication.
    (g) Limitation.--The task force shall not have rulemaking 
authority.
    (h) Report.--Not later than 270 days after the date on which the 
task force is convened under subsection (b), the task force shall 
submit to Congress a report that includes--
            (1) the strategy for disseminating best practices for pain 
        management (including chronic and acute pain) and prescribing 
        pain medication, as developed under subsection (e);
            (2) the results of a feasibility study on linking the best 
        practices described in paragraph (1) to receiving and renewing 
        registrations under section 303(f) of the Controlled Substances 
        Act (21 U.S.C. 823(f));
            (3) recommendations for effectively applying the best 
        practices described in paragraph (1) to improve prescribing 
        practices at medical facilities, including medical facilities 
        of the Veterans Health Administration and Indian Health 
        Service;
            (4) the modified and updated best practices described in 
        subsection (e)(4); and
            (5) the results of the examination and identification 
        conducted pursuant to subsection (e)(4), and recommendations 
        regarding--
                    (A) the development of new pharmacological, 
                nonpharmacological, and medical device alternatives to 
                opioids; and
                    (B) the improved utilization of pharmacological, 
                nonpharmacological, and medical device alternatives to 
                opioids that are currently available.

            Passed the House of Representatives May 11, 2016.

            Attest:

                                                 KAREN L. HAAS,

                                                                 Clerk.

A: (Sec. 1) This bill requires the Department of Health and Human Services to convene a Pain Management Best Practices Inter-Agency Task Force to: (1) review, modify, and update best practices for pain management and prescribing pain medication; and (2) examine and identify the need for, development of, and availability of medical alternatives to opioids (drugs with effects similar to opium, such as certain pain medications). The task force must submit a report that includes: (1) the modified and updated best practices; (2) a strategy for disseminating the best practices; (3) the feasibility of linking the best practices to Drug Enforcement Administration registration of manufacturers, distributors, and dispensers of controlled substances; (4) recommendations for effectively applying the best practices at medical facilities; and (5) recommendations regarding medical alternatives to opioids.
****
Q: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Taxpayer Right-To-Know Act of 
1997''.

SEC. 2. FINDINGS AND PURPOSES.

    (a) Findings.--The Congress finds the following:
            (1) Individual incomes taxes amount to one of the greatest 
        annual expenses for many Americans.
            (2) There is a great deal of uncertainty on the part of 
        taxpayers concerning where and how their income tax dollars are 
        spent.
            (3) Taxpayers do not receive any acknowledgment of payment 
        from the Internal Revenue Service nor any explanation itemizing 
        how their tax payments are spent.
            (4) There presently exists no straightforward way for a 
        taxpayer to determine exactly how much he or she paid for 
        specific governmental activities.
            (5) The failure to provide taxpayers with an itemized 
        listing showing how their tax dollars are spent contributes to 
        a lack of knowledge about the Government and subsequently to a 
        less informed electorate.
            (6) The Internal Revenue Service must update its technology 
        and treat taxpayer information as a strategic asset to improve 
        customer service.
            (7) Taxpayer education by the Internal Revenue Service 
        aimed at showing taxpayers how their tax dollars are spent 
        leads to increased compliance.
    (b) Purposes.--The purposes of this Act are as follows:
            (1) To educate individual income tax filers about how much 
        they contribute annually, in actual dollars and cents, to 
        various governmental programs, projects, and activities.
            (2) To improve the public's understanding of the Federal 
        Government.
            (3) To enhance the public's level of satisfaction with the 
        Internal Revenue Service.

SEC. 3. ITEMIZED INCOME TAX RECEIPT.

    (a) In General.--Chapter 77 of the Internal Revenue Code of 1986 
(relating to miscellaneous provisions) is amended by adding at the end 
the following new section:

``SEC. 7525. TAXPAYER REQUEST FOR INCOME TAX RECEIPT.

    ``(a) In General.--At the request of any taxpayer who files an 
individual income tax return, the Secretary shall send to such taxpayer 
an itemized receipt showing a proportionate allocation (in money terms) 
of the taxpayer's total tax payments among the major expenditure 
categories.
    ``(b) Total Tax Payments.--For purposes of subsection (a), total 
tax payments of an individual for any taxable year are--
            ``(1) the tax imposed by subtitle A for such taxable year 
        (as shown on his return), and
            ``(2) the tax imposed by section 3101 on wages received 
        during such taxable year.
    ``(c) Content of Tax Receipt.--
            ``(1) Major expenditure categories.--For purposes of 
        subsection (a), the major expenditure categories are:
                    ``(A) National defense.
                    ``(B) International affairs.
                    ``(C) Medicaid.
                    ``(D) Medicare.
                    ``(E) Means-tested entitlements.
                    ``(F) Domestic discretionary.
                    ``(G) Social Security.
                    ``(H) Interest payments.
                    ``(I) All other.
            ``(2) Other items on receipt.--In addition, the tax receipt 
        shall include selected examples of more specific expenditure 
        items, either at the budget function, subfunction, or program, 
        project, or activity levels, along with any other information 
        deemed appropriate by the Secretary and the Director of the 
        Office of Management and Budget to enhance taxpayer 
        understanding of the Federal budget.
    ``(d) Manner and Time of Request.--A request for a tax receipt as 
described in subsection (c) shall be made with respect to any taxable 
year at the time of filing the return imposed by chapter 1 for such 
taxable year. A receipt shall be made available to a requesting 
taxpayer as soon as practicable upon the processing of that taxpayer's 
Federal income tax return by the Internal Revenue Service.
    ``(e) Use of New Technologies.--The Internal Revenue Service is 
encouraged to utilize modern technologies such as electronic mail and 
the Internet to minimize the cost of sending receipts to taxpayers. The 
Internal Revenue Service shall establish an interactive program on its 
Internet website to allow taxpayers to generate income tax receipts on 
their own.
    ``(f) Cost.--No charge shall be imposed to cover any cost 
associated with the production or distribution of the tax receipt.
    ``(g) Regulations.--The Secretary may prescribe such regulations as 
may be necessary to carry out this section.''.
    (b) Clerical Amendment.--The table of sections for chapter 77 of 
such Code is amended by adding at the end the following new item:

                              ``Sec. 7525. Taxpayer request for income 
                                        tax receipt.''
    (c) Effective Date.--The amendments made by this section shall 
apply to taxable years beginning after December 31, 1997.

A:
Taxpayer Right-To-Know Act of 1997 - Amends the Internal Revenue Code to require the Secretary of the Treasury, at the request of a taxpayer, to send the taxpayer an itemized receipt showing a proportionate allocation of the taxpayer's payments among the major expenditure categories.
****